The use of rituximab, abatacept and Janus kinase inhibitors (JAKis) in individuals with rheumatoid arthritis (RA) was ...

Deuruxolitinib showed significant efficacy and safety in hair regrowth stimulation among adult patients with alopecia areata, ...

Andrew Rosenberg, DVM, DACVD, provided an overview of Janus kinase inhibitors for treating canine atopic dermatitis ...

Discover a study which demonstrates how rocatinlimab has shown significant improvements in treating durable atopic dermatitis ...

DelveInsight’s, “Janus Kinase Inhibitor Pipeline Insight 2024” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Janus Kinase (JAK) Inhibitor pipeline ...

When the session moderator asked whether the findings meant cardiovascular risk was no longer a worry with JAK inhibitors ...

Patients with IBD don’t face an increased risk for major adverse cardiovascular events when taking Janus kinase inhibitors ...

The following is a summary of “Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic ...

Growing awareness of axial spondyloarthritis among the public is a key driver. Government-led initiatives, healthcare camps, and a focus on disease prevention contribute to heightened awareness, ...

Andrew Rosenberg, DVM, DACVD, discusses the effectiveness of JAK inhibitors for treating allergy symptoms in animals ...

The panelist discusses how emerging targeted therapies like Janus kinase inhibitors and combination treatment approaches are ...